CORC  > 上海健康医学院
Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1.
Zhu Kai-Chang; Sun Jian-Mei; Shen Jian-Guo; Jin Ji-Zhong; Liu Feng; Xu Xiao-Lin; Chen Lin; Liu Lin-Tao; Lv Jia-Ju
刊名Oncology letters
2015
卷号10期号:4
关键词G0 phase LIM domain kinase 1 LNCaP cells PC-3 cells afzelin prostate cancer
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4269966
专题上海健康医学院
推荐引用方式
GB/T 7714
Zhu Kai-Chang,Sun Jian-Mei,Shen Jian-Guo,et al. Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1.[J]. Oncology letters,2015,10(4).
APA Zhu Kai-Chang.,Sun Jian-Mei.,Shen Jian-Guo.,Jin Ji-Zhong.,Liu Feng.,...&Lv Jia-Ju.(2015).Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1..Oncology letters,10(4).
MLA Zhu Kai-Chang,et al."Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1.".Oncology letters 10.4(2015).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace